Effect of the Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on Quality of Life in Individuals with NT1

Sleep Medicine 2026

View at publisher

Authors: Sheila Sivam, Samuel Hsiao, Y. Du, H. Romero, Tomas P Olsson

DOI: 10.1016/j.sleep.2025.107509

Cited by: 0

Fields of Study & Subjects

Sleep and Wakefulness Research Sleep and related disorders Obstructive Sleep Apnea Research